prospective trial to validate of efficacy of brachial plexus block duration in patients undergoing orthopedic upper arm surgery when patients are sadated by dexmedetomidine

Sedation with dexmedetomidine prolongs the analgesic duration of brachial plexus block in upper extremity orthopedic surgery: a randomized, double-blind, controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002138

Enrollment

102

Registered

2016-11-11

Start date

2016-07-08

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Brachial plexus block uses the 25 ml (1&#37

lidocaine and 0.75&#37

ropivacaine were mixed 1: 1 ratio) by supraclavicular approach. study group: The continuous infusion of Dexmedetomidine. clinically sadative dosage. Control group : midazolam injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: americal society of anesthesiologist physical status I-III , aged 20yrs~70yrs open reduction internal fixation (ORIF) for fractures of the radius or ulnar shortening surgery for ulnar impaction written informed consent

Exclusion criteria

Exclusion criteria: Refuse Brachial plexus block local infection, amide anesthetics(ropivacaine) hypersensitivity Hypersensitivity or allergy of dexmedetomidine Neuropathy Uncontrolled diabetes mellitus Significant pulmonary disease Significant cardiovascular disease

Design outcomes

Primary

Measure	Time frame
First analgesic requirement	—

Secondary

Measure	Time frame
First analgesic requirement ??? VAS( visual analog scales);used opioid total dose;vital sign (blood pressure, heart rate) , mRSS	—

Countries

Korea, Republic of

Contacts

Public ContactBoohwi Hong

Chungnam National University Hospital

koho0127@gmail.com+82-42-280-7840

Outcome results